Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Pharmacology|March 1, 1996
Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculatureS Bova, L Trevisi, P Debetto, et al.
Giornale Italiano Di Cardiologia|December 1, 1984
[Pharmacological and clinical research on the interaction of digitalis and amiodarone in heart disease patients with varying degrees of cardiac insufficiency]G Fornaro, P Rossi, R Padrini, et al.
International Journal of Clinical Pharmacology Research|January 1, 1983
Clinical evaluation of new antiarrhythmic agents: experiences with propafenoneF Furlanello, M Disertori, G Vergara, et al.
British Journal of Clinical Pharmacology|February 12, 1998
Tolerance to the repolarization effects of rac-sotalol during long-term treatmentR Padrini, M Gusella, M Al Bunni, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acidS D Ferrara, L Tedeschi, G Frison, et al.
Therapeutic Drug Monitoring|February 1, 1995
Verapamil and norverapamil plasma levels in infants and children during chronic oral treatmentD Piovan, R Padrini, G Svalato Moreolo, et al.
Cardiovascular Drugs and Therapy|June 1, 1993
Effect of dobutamine on left ventricular relaxation and filling phase in patients with ischemic heart disease and preserved systolic functionR Zeppellini, R Bolognesi, A Javernaro, et al.
Basic Research in Cardiology|September 1, 1996
Evaluation of the regional responsivity to ryanodine of human myocardium from patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathiesR Padrini, M Panfili, L Testolin, et al.
British Journal of Haematology|August 12, 2008
Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand diseaseM Sztukowska, L Gallinaro, M G Cattini, et al.
Atherosclerosis|January 1, 1986
Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemiaR Fellin, A Gasparotto, G Valerio, et al.
Pageof 7